封面
市場調查報告書
商品編碼
1055529

輸液泵軟件市場:增長,趨勢,Covid-19影響和預測(2022-2027)

Infusion Pump Software Market - Growth, Trends, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

據說慢性疾病增加等因素促進了輸液泵軟件市場的增長。

此外,手術和印度和中國的新興市場市場上有增加,並引入輸液泵軟件也已經提出,輸液泵軟件市場為輸液帶來了一個主要的增長機會泵軟件市場。

此外,手術手術的增加正在擴展,輸液泵的機會在每個國家都在擴大,最終促進用於輸液泵的軟件的需求。

在本報告中,我們調查了世界的輸液泵軟件市場,通過市場概覽,通過輸入,使用,最終用戶,區域趨勢和進入市場的公司概況。

內容

第1章簡介

第2章測量方法

第3章執行摘要

第4章市場力學

  • 市場概述
  • 市場推廣因素
    • 預防慢性病預防率
    • 增加便攜式和家用醫用輸液泵的需求
    • 增加全球手術人群的數量
  • 市場抑制因子
    • 召回產品
    • 遙控院缺乏無線連接
  • Porter的五個力分析

第5章市場細分

  • 類型按類型
    • 臨床工作流軟件
    • 劑量錯誤減少軟件(DERS)
    • 其他
  • 通過申請
    • 疼痛,麻醉管理
    • 胰島素注射
    • 化療
  • 通過最終用戶
    • 醫院
    • 門診外科中心
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東,非洲
    • 南美洲

第6章衝突行為

  • 公司簡介
    • Baxter International
    • B. Braun Medical Inc.
    • Becton, Dickinson and Company
    • Fresenius Kabi
    • FLOWONIX MEDICAL INC
    • ICU Medical Inc.
    • Medtronic
    • Merck KGaA
    • Q Core Medical Ltd
    • Smiths Medical

第7章 市場機會與動向

簡介目錄
Product Code: 68129

Factors such as rising incidence of chronic diseases coupled with the rapid growth in the geriatric population are some of the major factors that are augmenting the growth of infusion pumps software. Additionally, increasing volume of surgical procedures performed and existence of untapped, emerging markets such as India and China with growing adoption of infusion pump software are offering substantial growth opportunities in the Infusion Pump Software Market. As per the OECD stats, in Canada, the number of surgeries performed was 378,448 during 2013 and it increased to 396,218 in 2017. In France, surgeries performed in 2014 was 773,308 and it raised to 863,837 by 2017. This rising trend of the number of surgical procedures performed is indicating that there is a growing opportunity for the infusion pumps in such countries which is ultimately driving the demand for the software used for infusion pump.

Key Market Trends

Dose Error Reduction Software segment Holds Significant Share in Infusion Pump Software Market

  • Though the patient safety is the major principle of health care, sometimes medication-related errors do exist and they have a significant impact. In 2017, the World Health Organization itself made it one of the main health challenges of our times to reduce medication errors by 50% within the next 5 years.
  • In order to prevent the consequent harm, systems and procedures need to be put in place so that the right patient receives the right medication in the right dose, via the right means and at the right time, Hence, Dose Error Reduction Software (DERS) software is the key for ensuring patient safety as it offers advanced safety features for the infusion pumps and hence, it is estimated to grow significantly owing to the increasing number of medication errors occur while using infusion pumps.
  • In August 2019, Baxter received CE marking of the EVO IQ Infusion System. The Evo IQ Infusion System features a scalable platform and user-centric design that includes an advanced drug library and dose error reduction software to promote patient safety.

North America dominate the Global Infusion Pump Software Market

  • The current growth of the North America infusion pump software market can be primarily attributed to home healthcare segment and patients and physicians, who are steadily adopting new technologically advanced products for regular treatment of chronic disease conditions.
  • On the other side, the market is driven by increased patient awareness, growing prevalence of chronic diseases and increasing number of surgeries performed in the region and need to control escalating healthcare costs, infusion pump software market in the region has been experiencing a significant growth.
  • According to the Journal of Infectious Disease Adviser, approximately 27 million surgical procedures are performed in the United States each year.
  • In February 2019, Flowonix Medical, Inc. received the United States Food and Drug Administration (FDA) market approval for their Maestro Infusion Pump Software Upgrade for Clinician Programmers.

Competitive Landscape

In Global Infusion Pump Software Market is moderately competitive and the major players are focused on expanding their business in different areas by adopting various market strategies such as partnerships, collaborations, acquisitions and mergers etc. Key developments of the market include in August 2019, B. Braun Medical Inc. collaborated with Guard RFID Solutions Inc.'s, as a part of collaboration, B. Braun Space Infusion pump with DoseTrac Infusion Management Software, which communicates with GuardRFID's AllGuard RFID software platform providing pump status and availability.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic Diseases
    • 4.2.2 Rising Demand for Ambulatory and Home Care Infusion Pumps
    • 4.2.3 Increasing Number of Surgeries Globally
  • 4.3 Market Restraints
    • 4.3.1 Product Recalls
    • 4.3.2 Lack of Wireless Connectivity in Remote Hospitals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Clinical Workflow Software
    • 5.1.2 Dose Error Reduction Software (DERS)
    • 5.1.3 Others
  • 5.2 By Application
    • 5.2.1 Pain & Anesthesia Management
    • 5.2.2 Insulin Infusion
    • 5.2.3 Chemotherapy
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Baxter International
    • 6.1.2 B. Braun Medical Inc.
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 Fresenius Kabi
    • 6.1.5 FLOWONIX MEDICAL INC
    • 6.1.6 ICU Medical Inc.
    • 6.1.7 Medtronic
    • 6.1.8 Merck KGaA
    • 6.1.9 Q Core Medical Ltd
    • 6.1.10 Smiths Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS